Overview
David Ashley is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Ashley is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri. Dr. Ashley is currently accepting new patients.
His clinical research consists of co-authoring 137 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Acute Lymphoblastic Leukemia (ALL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Duke Blood Cancer Center
I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is rated as an Elite provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
University Of North Carolina At Chapel Hill
Hendrik Vandeventer is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Vandeventer is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Aplastic Anemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Vandeventer is currently accepting new patients.
University Of North Carolina At Chapel Hill
Katarzyna Jamieson is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Jamieson is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Jamieson is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstrocytomaDr. Ashley isElite. Learn about Astrocytoma.
- Brain TumorDr. Ashley isElite. Learn about Brain Tumor.
- GlioblastomaDr. Ashley isElite. Learn about Glioblastoma.
- GliomaDr. Ashley isElite. Learn about Glioma.
- Gliomatosis CerebriDr. Ashley isElite. Learn about Gliomatosis Cerebri.
- Distinguished
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Ashley isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Embryonal Tumor with Multilayered RosettesDr. Ashley isDistinguished. Learn about Embryonal Tumor with Multilayered Rosettes.
- GliosarcomaDr. Ashley isDistinguished. Learn about Gliosarcoma.
- NeuroepitheliomaDr. Ashley isDistinguished. Learn about Neuroepithelioma.
- OligodendrogliomaDr. Ashley isDistinguished. Learn about Oligodendroglioma.
- Advanced
- EpendymomaDr. Ashley isAdvanced. Learn about Ependymoma.
- GangliogliomaDr. Ashley isAdvanced. Learn about Ganglioglioma.
- MedulloblastomaDr. Ashley isAdvanced. Learn about Medulloblastoma.
- Metastatic Brain TumorDr. Ashley isAdvanced. Learn about Metastatic Brain Tumor.
- Pediatric Low-Grade Glioma (pLGG)Dr. Ashley isAdvanced. Learn about Pediatric Low-Grade Glioma (pLGG).
- Posterior Fossa TumorDr. Ashley isAdvanced. Learn about Posterior Fossa Tumor.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Ashley isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Soft Tissue SarcomaDr. Ashley isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Ataxia-TelangiectasiaDr. Ashley isExperienced. Learn about Ataxia-Telangiectasia.
- Brain Stem CancerDr. Ashley isExperienced. Learn about Brain Stem Cancer.
- Breast CancerDr. Ashley isExperienced. Learn about Breast Cancer.
- Diffuse Midline Glioma H3 K27M-MutantDr. Ashley isExperienced. Learn about Diffuse Midline Glioma H3 K27M-Mutant.